UBIO

Proshares UltraPro NASDAQ Biotechnology

Delisted

UBIO was delisted on the 27th of March, 2020.

7 hedge funds and large institutions have $3.18M invested in Proshares UltraPro NASDAQ Biotechnology in 2016 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
7
Holders Change
Holders Change %
0%
% of All Funds
0.19%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
2
Reduced
2
Closed
3
Calls
$1.04M
Puts
$834K
Net Calls
+$203K
Net Calls Change
-$379K
Name Holding Trade Value Shares
Change
Shares
Change %
VF
1
Virtu Financial
New York
$1.97M +$632K +29,800 +47%
TRCT
2
Tower Research Capital (TRC)
New York
$697K +$677K +31,884 +3,332%
Jane Street
3
Jane Street
New York
$276K +$276K +13,027 New
Citadel Advisors
4
Citadel Advisors
Florida
$212K +$212K +9,976 New
UBS Group
5
UBS Group
Switzerland
$20K -$104K -4,969 -84%
Morgan Stanley
6
Morgan Stanley
New York
$13K +$13K +592 New
Susquehanna International Group
7
Susquehanna International Group
Pennsylvania
-$757K -31,971 Closed
Creative Planning
8
Creative Planning
Kansas
-$5K -200 Closed
Simplex Trading
9
Simplex Trading
Illinois
-$2K -97 Closed